José Federico
Díaz González
Catedrático de Universidad
Hospital Universitario Marqués de Valdecilla
Santander, EspañaPublicacións en colaboración con investigadores/as de Hospital Universitario Marqués de Valdecilla (29)
2024
-
The complement system is linked to insulin resistance in patients with systemic lupus erythematosus
Clinical and experimental rheumatology, Vol. 42, Núm. 1, pp. 115-121
2023
-
Development of a web tool to calculate the cumulative dose of glucocorticoids
Reumatologia Clinica, Vol. 19, Núm. 1, pp. 1-5
-
Full characterization of the three pathways of the complement system in patients with systemic lupus erythematosus
Frontiers in Immunology, Vol. 14
-
HDL Cholesterol Efflux and the Complement System Are Linked in Systemic Lupus Erythematosus
Journal of Clinical Medicine, Vol. 12, Núm. 16
2022
-
Profibrotic Role of Inducible Heat Shock Protein 90α Isoform in Systemic Sclerosis
Journal of immunology (Baltimore, Md. : 1950), Vol. 209, Núm. 1, pp. 38-48
2021
-
Differences in Capacity of High-Density Lipoprotein Cholesterol Efflux Between Patients With Systemic Lupus Erythematosus and Rheumatoid Arthritis
Arthritis Care and Research, Vol. 73, Núm. 11, pp. 1590-1596
-
Role of targeted therapies in rheumatic patients on COVID-19 outcomes: Results from the COVIDSER study
RMD Open, Vol. 7, Núm. 3
2020
-
Fracture risk assessment in the general population in Spain by FRAX® algorithm. EPISER2016 study
Medicina Clinica, Vol. 154, Núm. 5, pp. 163-170
-
Impaired HDL cholesterol efflux capacity in systemic lupus erythematosus patients is related to subclinical carotid atherosclerosis
Rheumatology (Oxford, England), Vol. 59, Núm. 10, pp. 2847-2856
-
Prevalence of fibromyalgia and associated factors in Spain
Clinical and experimental rheumatology, Vol. 38, Núm. 1, pp. 47-52
-
The prevalence of rheumatoid arthritis in Spain
Scientific Reports, Vol. 10, Núm. 1
2019
-
Efficacy and safety of biological therapy compared to synthetic immunomodulatory drugs or placebo in the treatment of Behçet’s disease associated uveitis: a systematic review
Rheumatology International, Vol. 39, Núm. 1, pp. 47-58
-
Prevalence of rheumatic diseases in adult population in Spain (EPISER 2016 study): Aims and methodology
Reumatologia Clinica, Vol. 15, Núm. 2, pp. 90-96
2017
-
HDL cholesterol efflux capacity in rheumatoid arthritis patients: Contributing factors and relationship with subclinical atherosclerosis
Arthritis Research and Therapy, Vol. 19, Núm. 1
-
Intravenous administration of expanded allogeneic adipose-derived mesenchymal stem cells in refractory rheumatoid arthritis (Cx611): Results of a multicentre, dose escalation, randomised, singleblind, placebo-controlled phase Ib/IIa clinical trial
Annals of the Rheumatic Diseases, Vol. 76, Núm. 1, pp. 196-202
-
Lipoprotein(a) concentrations in rheumatoid arthritis on biologic therapy: Results from the CARdiovascular in rheuMAtology study project
Journal of Clinical Lipidology, Vol. 11, Núm. 3, pp. 749-756.e3
2015
-
Cardiovascular morbidity and associated risk factors in Spanish patients with chronic inflammatory rheumatic diseases attending rheumatology clinics: Baseline data of the CARMA Project
Seminars in Arthritis and Rheumatism, Vol. 44, Núm. 6, pp. 618-626
-
Cardiovascular risk assessment in rheumatoid arthritis: What goals should be achieved?
Seminars in Arthritis and Rheumatism
-
Erratum to "Cardiovascular morbidity and associated risk factors in Spanish patients with chronic inflammatory rheumatic diseases attending rheumatology clinics: Baseline data of the CARMA Project" [Semin Arthritis Rheum 44 (2015) 618-626]
Seminars in Arthritis and Rheumatism
-
Relationship between endothelial dysfunction and osteoprotegerin, vitamin D, and bone mineral density in patients with rheumatoid arthritis
Clinical and Experimental Rheumatology, Vol. 33, Núm. 2, pp. 241-249